Aarti Drugs

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE767A01016
  • NSEID: AARTIDRUGS
  • BSEID: 524348
INR
484.55
-14.8 (-2.96%)
BSENSE

Nov 20

BSE+NSE Vol: 3.13 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
826.24
702.78
720.30
601.71
652.79
590.51
676.76
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
826.24
702.78
720.30
601.71
652.79
590.51
676.76
Raw Material Cost
477.33
469.35
427.19
334.52
385.06
357.25
373.78
Purchase of Finished goods
33.13
21.38
33.32
22.51
30.64
28.61
23.13
(Increase) / Decrease In Stocks
-11.41
-63.13
-10.09
29.61
-7.41
-12.47
38.64
Employee Cost
37.13
36.51
32.28
33.16
33.07
30.80
31.35
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
154.70
140.47
141.80
126.88
127.15
112.24
116.53
Total Expenditure (Excl Depreciation)
690.88
604.58
624.50
546.68
568.51
516.43
583.43
Operating Profit (PBDIT) excl Other Income
135.36
98.20
95.80
55.03
84.28
74.08
93.33
Other Income
2.55
0.81
0.76
1.23
0.09
0.31
1.87
Operating Profit (PBDIT)
137.91
99.01
96.56
56.26
84.37
74.39
95.20
Interest
9.63
9.22
8.16
9.29
7.70
8.56
9.16
Exceptional Items
0.00
-2.09
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
128.28
87.70
88.40
46.97
76.67
65.83
86.04
Depreciation
19.00
18.46
18.04
17.95
16.26
14.72
14.88
Profit Before Tax
109.28
69.24
70.36
29.02
60.41
51.11
71.16
Tax
26.51
19.11
15.10
-11.53
15.25
-2.86
8.39
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
82.77
50.13
55.26
40.55
45.16
53.97
62.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
82.77
50.13
55.26
40.55
45.16
53.97
62.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.17
-0.04
0.07
0.01
-0.12
0.06
-0.09
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
82.94
50.17
55.19
40.54
45.28
53.91
62.86
Equity Capital
91.27
91.27
91.27
91.27
91.27
91.27
91.27
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
9.09
5.5
6.05
4.44
4.96
5.91
6.89
Diluted Earnings per share
9.07
5.49
6.05
4.44
4.95
5.91
6.88
Operating Profit Margin (Excl OI)
16.38%
13.97%
13.3%
9.15%
12.91%
12.55%
13.79%
Gross Profit Margin
15.53%
12.48%
12.27%
7.81%
11.74%
11.15%
12.71%
PAT Margin
10.02%
7.13%
7.67%
6.74%
6.92%
9.14%
9.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 17.57% vs -2.43% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is 65.32% vs -9.10% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 37.84% vs 2.51% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 4.45% vs 12.99% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Aarti Drugs With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
826.24
49.92
776.32
1,555.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
826.24
49.92
776.32
1,555.13%
Raw Material Cost
477.33
9.98
467.35
4,682.87%
Purchase of Finished goods
33.13
0.00
33.13
(Increase) / Decrease In Stocks
-11.41
1.71
-13.12
-767.25%
Employee Cost
37.13
5.92
31.21
527.20%
Power Cost
0.00
9.79
-9.79
-100.00%
Manufacturing Expenses
0.00
1.24
-1.24
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
154.70
22.19
132.51
597.16%
Total Expenditure (Excl Depreciation)
690.88
50.83
640.05
1,259.20%
Operating Profit (PBDIT) excl Other Income
135.36
-0.91
136.27
14,974.73%
Other Income
2.55
3.80
-1.25
-32.89%
Operating Profit (PBDIT)
137.91
2.89
135.02
4,671.97%
Interest
9.63
8.36
1.27
15.19%
Exceptional Items
0.00
-1.17
1.17
100.00%
Gross Profit (PBDT)
128.28
-6.64
134.92
2,031.93%
Depreciation
19.00
4.54
14.46
318.50%
Profit Before Tax
109.28
-11.17
120.45
1,078.33%
Tax
26.51
2.67
23.84
892.88%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
82.77
-13.84
96.61
698.05%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
82.77
-13.84
96.61
698.05%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-0.17
0.00
-0.17
Other related items
0.00
0.00
0.00
Consolidated Net Profit
82.94
-13.84
96.78
699.28%
Equity Capital
91.27
13.02
78.25
601.00%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
9.09
-1.06
10.15
957.55%
Diluted Earnings per share
9.07
-1.19
10.26
862.18%
Operating Profit Margin (Excl OI)
16.38%
-1.82%
0.00
18.20%
Gross Profit Margin
15.53%
-13.30%
0.00
28.83%
PAT Margin
10.02%
-27.72%
0.00
37.74%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 826.24 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 17.57% vs -2.43% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 26.57% vs 9.10% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 82.94 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 65.32% vs -9.10% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 83.17% vs 29.33% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 135.36 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 37.84% vs 2.51% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 60.61% vs 25.70% in Sep 2025

Quarterly - Interest
Interest 9.63 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 4.45% vs 12.99% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 25.06% vs -13.77% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.38%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025